Michel White

Summary

Affiliation: Montreal Heart Institute
Country: Canada

Publications

  1. ncbi request reprint Effect of left ventricular assist device bridging to transplantation on donor waiting time and outcomes in Canada
    Michel Carrier
    Department of Surgery, Montreal Heart Institute, Montreal, Canada
    Can J Cardiol 20:501-4. 2004
  2. ncbi request reprint Subclinical inflammation and prothrombotic state in heart transplant recipients: impact of cyclosporin microemulsion vs. tacrolimus
    Michel White
    Research Center, Montreal Heart Institute, Montreal, Quebec, Canada
    Transplantation 82:763-70. 2006
  3. ncbi request reprint Effects of combined candesartan and ACE inhibitors on BNP, markers of inflammation and oxidative stress, and glucose regulation in patients with symptomatic heart failure
    Michel White
    Research Center, Montreal Heart Institute and Universite de Montreal, Montreal, Quebec, Canada
    J Card Fail 13:86-94. 2007
  4. ncbi request reprint Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support
    Michel White
    Department of Medicine, Montreal Heart Institute, Montreal, Quebec, Canada, H1T 1C8
    Clin Sci (Lond) 110:483-9. 2006
  5. ncbi request reprint Basiliximab and rabbit anti-thymocyte globulin for prophylaxis of acute rejection after heart transplantation: a non-inferiority trial
    Michel Carrier
    Montreal Heart Institute and the Université de Montréal, Montreal, Quebec, Canada
    J Heart Lung Transplant 26:258-63. 2007
  6. ncbi request reprint Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine
    Michel White
    Research Center of Montreal Heart Institute, Montreal, Quebec
    J Heart Lung Transplant 24:798-809. 2005
  7. ncbi request reprint Effects of AGTR1 A1166C gene polymorphism in patients with heart failure treated with candesartan
    Simon de Denus
    Faculty of Pharmacy, University of Montreal, Montreal Heart Institute, Montreal, QC, Canada
    Ann Pharmacother 42:925-32. 2008
  8. ncbi request reprint Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial
    Eileen O'Meara
    Montreal Heart Institute, Montreal Heart Institute Coordinating Center, and Université de Montréal, Montreal, QC, Canada
    Circ Heart Fail 5:586-93. 2012
  9. doi request reprint Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and function in patients with heart failure not treated with a beta-blocker
    Michel White
    Research Center, Montreal Heart Institute and Universite de Montreal, Montreal, Quebec, Canada
    Ther Adv Cardiovasc Dis 3:113-21. 2009
  10. ncbi request reprint Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction: a retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials
    Simon de Denus
    Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada
    Am Heart J 152:705-12. 2006

Detail Information

Publications59

  1. ncbi request reprint Effect of left ventricular assist device bridging to transplantation on donor waiting time and outcomes in Canada
    Michel Carrier
    Department of Surgery, Montreal Heart Institute, Montreal, Canada
    Can J Cardiol 20:501-4. 2004
    ..LVAD patients were activated on the waiting list as soon as they were in suitable clinical status...
  2. ncbi request reprint Subclinical inflammation and prothrombotic state in heart transplant recipients: impact of cyclosporin microemulsion vs. tacrolimus
    Michel White
    Research Center, Montreal Heart Institute, Montreal, Quebec, Canada
    Transplantation 82:763-70. 2006
    ..tacrolimus immunoprophylaxis on these parameters...
  3. ncbi request reprint Effects of combined candesartan and ACE inhibitors on BNP, markers of inflammation and oxidative stress, and glucose regulation in patients with symptomatic heart failure
    Michel White
    Research Center, Montreal Heart Institute and Universite de Montreal, Montreal, Quebec, Canada
    J Card Fail 13:86-94. 2007
    ....
  4. ncbi request reprint Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support
    Michel White
    Department of Medicine, Montreal Heart Institute, Montreal, Quebec, Canada, H1T 1C8
    Clin Sci (Lond) 110:483-9. 2006
    ..Short-term inotropic support improves functional status and reduces indices of inflammation and oxidative stress in patients with decompensated CHF...
  5. ncbi request reprint Basiliximab and rabbit anti-thymocyte globulin for prophylaxis of acute rejection after heart transplantation: a non-inferiority trial
    Michel Carrier
    Montreal Heart Institute and the Université de Montréal, Montreal, Quebec, Canada
    J Heart Lung Transplant 26:258-63. 2007
    ..We tested the non-inferiority of basiliximab vs rabbit anti-thymocyte globulin (RATG) on the incidence of acute rejection 6 months after transplantation...
  6. ncbi request reprint Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine
    Michel White
    Research Center of Montreal Heart Institute, Montreal, Quebec
    J Heart Lung Transplant 24:798-809. 2005
    ..The impact of conversion from cyclosporine microemulsion (Neoral) to tacrolimus (Prograf) in a large randomized study of stable heart transplant recipients with treated but persistent mild dyslipidemia is reported...
  7. ncbi request reprint Effects of AGTR1 A1166C gene polymorphism in patients with heart failure treated with candesartan
    Simon de Denus
    Faculty of Pharmacy, University of Montreal, Montreal Heart Institute, Montreal, QC, Canada
    Ann Pharmacother 42:925-32. 2008
    ..It is currently impossible to determine which patient will benefit from the addition of an ARB...
  8. ncbi request reprint Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial
    Eileen O'Meara
    Montreal Heart Institute, Montreal Heart Institute Coordinating Center, and Université de Montréal, Montreal, QC, Canada
    Circ Heart Fail 5:586-93. 2012
    ..Our primary objective was to assess the impact of mineralocorticoid receptor antagonists on cardiovascular mortality in patients with AF and HF enrolled in the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial...
  9. doi request reprint Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and function in patients with heart failure not treated with a beta-blocker
    Michel White
    Research Center, Montreal Heart Institute and Universite de Montreal, Montreal, Quebec, Canada
    Ther Adv Cardiovasc Dis 3:113-21. 2009
    ..The objective of this study was to investigate the changes in neurohormones and LV volumes and ejection fraction in patients treated with enalapril, candesartan, or enalapril plus candesartan without concomitant beta-blocker therapy...
  10. ncbi request reprint Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction: a retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials
    Simon de Denus
    Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada
    Am Heart J 152:705-12. 2006
    ..Limited data are available to predict the occurrence of hyperkalemia. Risk assessment is complicated by the lack of consistency of definition between trials...
  11. pmc Results following implantation of mechanical circulatory support systems: the Montreal Heart Institute experience
    Ismail El-Hamamsy
    Department of Cardiac Surgery, Montreal Heart Institute and Universite de Montreal, Montreal, Quebec
    Can J Cardiol 25:107-10. 2009
    ..Accepted indications include bridging to transplantation or recovery. The present study reviewed the results following MCSS implantation at the Montreal Heart Institute (Montreal, Quebec)...
  12. pmc Bucindolol, systolic blood pressure, and outcomes in systolic heart failure: a prespecified post hoc analysis of BEST
    Michel White
    Montreal Heart Institute, Montreal, Quebec, Canada
    Can J Cardiol 28:354-9. 2012
    ..Because SBP is an important predictor of response to β-blocker therapy, the BEST protocol prespecified a post hoc analysis to determine whether the effect of bucindolol varied by baseline SBP...
  13. ncbi request reprint Decreased heart rate recovery after exercise in patients with congestive heart failure: effect of beta-blocker therapy
    Normand Racine
    Department of Medicine, Montreal Heart Institute, Quebec, Canada
    J Card Fail 9:296-302. 2003
    ..We investigated the changes in HRR and assessed the impact of beta-blockade therapy on these parameters in patients with symptomatic congestive heart failure (CHF)...
  14. pmc Adherence level of antihypertensive agents in coronary artery disease
    Sylvie Perreault
    Faculties of Pharmacy and Medicine, University of Montreal, Montreal, Quebec, Canada
    Br J Clin Pharmacol 69:74-84. 2010
    ....
  15. pmc Two decades of cardiac transplantation at the Montreal Heart Institute
    Frederic Jacques
    Department of Surgery, Montreal Heart Institute, Universite de Montreal, Montreal, Canada
    Can J Cardiol 24:217-21. 2008
    ..After nine patients transplanted in the precyclosporine era, the program was stopped. With the advent of cyclosporine, the program was reactivated in 1983...
  16. doi request reprint Cardiac remodeling with rhythm versus rate control strategies for atrial fibrillation in patients with heart failure: insights from the AF-CHF echocardiographic sub-study
    Valérie Henrard
    Montreal Heart Institute, Universite de Montreal, Montreal, Quebec, Canada
    Int J Cardiol 165:430-6. 2013
    ..This echocardiographic sub-study was designed to compare the effects of the two treatment strategies on LV ejection fraction (LVEF), chamber volumes and dimensions, valvular regurgitation and functional status...
  17. doi request reprint Left ventricular versus simultaneous biventricular pacing in patients with heart failure and a QRS complex ≥120 milliseconds
    Bernard Thibault
    Montreal Heart Institute, 5000 Belanger St, Montreal, QC, Canada H1T 1C8
    Circulation 124:2874-81. 2011
    ..Left ventricular (LV) pacing alone may theoretically avoid deleterious effects of right ventricular pacing...
  18. doi request reprint Effects of angiotensin-converting enzyme inhibitor versus valsartan on cellular signaling events in heart transplant
    Michel White
    Department of Medicine, Montreal Heart Institute and University of Montreal, Montreal, Quebec, Canada
    Ann Pharmacother 43:831-9. 2009
    ..The changes in the cardiac angiotensin system signaling pathways in the human heart in response to ACE inhibitors versus ARBs have been incompletely studied...
  19. doi request reprint Association between renal function and CYP3A5 genotype in heart transplant recipients treated with calcineurin inhibitors
    Simon de Denus
    Faculty of Pharmacy, Universite de Montreal, Montreal, Quebec, Canada
    J Heart Lung Transplant 30:326-31. 2011
    ..The aim of this study was to evaluate the association between polymorphisms of the genes encoding these proteins and the long-term renal function of heart transplant recipients treated with calcineurin inhibitors...
  20. doi request reprint Impact of better adherence to statin agents in the primary prevention of coronary artery disease
    Sylvie Perreault
    Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada
    Eur J Clin Pharmacol 65:1013-24. 2009
    ..Statins reduce cardiovascular morbidity and mortality after continuous treatment. Studies have shown that less than 50% of patients take 80% or more of prescribed doses 1 year after starting therapy...
  21. pmc Temporal variations in hematocrit values in patients with left ventricular dysfunction: Relationship with cause-specific mortality and morbidity and optimal monitoring--further insights from SOLVD
    Simon de Denus
    Faculty of Pharmacy, University of Montreal, Montreal, Canada
    Can J Cardiol 24:45-8. 2008
    ..Currently, the relationship between temporal variations in hematocrit and specific causes of mortality and morbidity, as well as the most appropriate way to monitor changes in hematocrit, is unknown...
  22. ncbi request reprint Cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trial
    Bernard Thibault
    Montreal Heart Institute, Universite de Montreal, Montreal, QB, Canada
    Circulation 127:873-81. 2013
    ..Although the benefits of cardiac resynchronization therapy are well established in selected patients with heart failure and a prolonged QRS duration, salutary effects in patients with narrow QRS complexes remain to be demonstrated...
  23. doi request reprint Differences in biomarkers in patients with heart failure with a reduced vs a preserved left ventricular ejection fraction
    Simon de Denus
    Research Center, Montreal Heart Institute and Universite de Montreal, Montreal, Quebec, Canada
    Can J Cardiol 28:62-8. 2012
    ..The objectives of this study were to compare the concentrations and correlation of biomarkers of inflammation, extracellular matrix (ECM) turnover and neurohormonal activation between these populations...
  24. pmc Heart rate recovery--a potential marker of clinical outcomes in heart failure patients receiving beta-blocker therapy
    Richard J Sheppard
    Sir Mortimer B Davis Jewish General Hospital, McGill University, Montreal, Quebec, Canada
    Can J Cardiol 23:1135-8. 2007
    ....
  25. ncbi request reprint Effects of angiotensin-converting enzyme inhibitor plus irbesartan on maximal and submaximal exercise capacity and neurohumoral activation in patients with congestive heart failure
    Martine Blanchet
    Department of Medicine, Division of Cardiology, Montreal Heart Institute, Montreal, Quebec, Canada
    Am Heart J 149:938.e1-7. 2005
    ....
  26. doi request reprint PRKCB is associated with calcineurin inhibitor-induced renal dysfunction in heart transplant recipients
    Kim Lachance
    University of Montreal, Quebec, Canada
    Pharmacogenet Genomics 22:336-43. 2012
    ..The secondary objective was to investigate the effect of candidate genes related to the RAAS, natriuretic peptides, and other elements involved in the intracellular signaling of these pathways...
  27. ncbi request reprint Relationship between adherence level to statins, clinical issues and health-care costs in real-life clinical setting
    Alice Dragomir
    Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada
    Value Health 13:87-94. 2010
    ..Low adherence to statins may have a significant impact on clinical issues and health-care costs. The objective is to evaluate the impact of low adherence to statins on clinical issues and direct health-care costs...
  28. pmc Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF)
    Maryse Palardy
    Department of Medicine, Montreal Heart Institute, Montreal, Canada
    Can J Cardiol 24:709-13. 2008
    ....
  29. ncbi request reprint Temporal increases in subclinical levels of inflammation are associated with adverse clinical outcomes in patients with left ventricular dysfunction
    Simon de Denus
    Faculty of Pharmacy, University of Montreal, Montreal, Canada
    J Card Fail 12:353-9. 2006
    ..The role of temporal changes of more conventional markers of inflammation, such as the white blood cell (WBC) count, on clinical outcomes remains largely unknown...
  30. doi request reprint Prognostic value of the physical examination in patients with heart failure and atrial fibrillation: insights from the AF-CHF trial (atrial fibrillation and chronic heart failure)
    Guillem Caldentey
    Montreal Heart Institute, Universite de Montreal, Montreal, Quebec, Canada
    JACC Heart Fail 2:15-23. 2014
    ..This study sought to assess the prognostic value of physical examination in a modern treated heart failure population...
  31. doi request reprint Angiotensin II signalling and calcineurin in cardiac fibroblasts: differential effects of calcineurin inhibitors FK506 and cyclosporine A
    Michel White
    Montreal Heart Institute, University of Montreal, Montreal, QC, Canada
    Ther Adv Cardiovasc Dis 6:5-14. 2012
    ....
  32. pmc An unusual case of giant cell myocarditis missed in a Heartmate-2 left ventricle apical-wedge section: a case report and review of the literature
    Kim Anderson
    Department of Medicine, Montreal Heart Institute, University of Montreal, 5000, Belanger East, Montreal, QC, H1T 1C8, Canada
    J Cardiothorac Surg 8:12. 2013
    ..To our knowledge, this is the first reported case of GCM following an acute lymphocytic myocarditis and the second GCM case associated with B-cell lymphoma...
  33. ncbi request reprint Incidence and prognosis of cancer following heart transplantation using RATG induction therapy
    Ismail El-Hamamsy
    Department of Cardiovascular Surgery, Montreal Heart Institute and University of Montreal, Quebec, Canada
    Transpl Int 18:1280-5. 2005
    ..No individual risk factors allow predicting its development. In the present cohort, RATG does not have carcinogenic effects following transplantation, but is associated with a more precocious development of malignancies...
  34. ncbi request reprint Impact of ezetimibe on cholesterol subfractions in dyslipidemic cardiac transplant recipients receiving statin therapy
    Vy Van Le
    Research Center, Montreal Heart Institute andUniversité de Montré al, Montreal, QC, Canada
    Clin Transplant 23:249-55. 2009
    ..The effects of ezetimibe in addition to statins therapy and its relationship with the magnitude of dyslipidemia and statins utilization have not been studied in cardiac transplant recipients...
  35. pmc Successful explantation of a left ventricular assist device following acute fulminant myocarditis
    Ismail El-Hamamsy
    Department of Cardiovascular Surgery, Montreal Heart Institute, Universite de Montreal, Quebec
    Can J Cardiol 22:507-8. 2006
    ..LV function recovered to normal after one week of support from an LV assist device. The device was explanted and the patient is showing a good outcome with a normalized LV function...
  36. doi request reprint High-intensity interval exercise in chronic heart failure: protocol optimization
    Philippe Meyer
    University Hospital of Geneva, Geneva, Switzerland
    J Card Fail 18:126-33. 2012
    ..Therefore, we compared acute cardiopulmonary responses to 4 different HIIE protocols to identify the optimal one...
  37. ncbi request reprint Lack of long-term benefits of a 6-month heart failure disease management program
    Viviane Nguyen
    Montreal Heart Institute Research Center, Montreal, Quebec, Canada
    J Card Fail 13:287-93. 2007
    ..Despite these encouraging results, it is unknown if these beneficial effects are sustained...
  38. pmc Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure
    Philippe Meyer
    Montreal Heart Institute, Montreal, Quebec, Canada
    Circulation 121:252-8. 2010
    ..Studies of the effect of right ventricular ejection fraction (RVEF) on outcomes in heart failure (HF) are limited by small sample size and short follow-up...
  39. doi request reprint Cardiac signaling molecules and plasma biomarkers after cardiac transplantation: impact of tacrolimus versus cyclosporine
    Michel White
    Department of Medicine, Montreal Heart Institute and Universite de Montreal, Montreal, Quebec, Canada Electronic address
    J Heart Lung Transplant 32:1222-32. 2013
    ....
  40. doi request reprint Evaluation of resynchronization therapy for heart failure in patients with a QRS duration greater than 120 ms (GREATER-EARTH) trial: rationale, design, and baseline characteristics
    Bernard Thibault
    Montreal Heart Institute and Universite de Montreal, Montreal, Quebec, Canada
    Can J Cardiol 27:779-86. 2011
    ..Despite its demonstrated salutary effects on clinical evolution, left ventricular (LV) function, and overall survival, at least 30% of patients fail to respond to CRT...
  41. doi request reprint Hemodynamic and clinical benefits associated with chronic sildenafil therapy in advanced heart failure: experience of the Montréal Heart Institute
    Brian J Potter
    Universite de Montreal, Montreal, Quebec, Canada
    Can J Cardiol 28:69-73. 2012
    ..The objective of this investigation was to report on a single centre's experience of open-label chronic sildenafil therapy in patients with advanced HF...
  42. pmc Impact of adherence to statins on chronic heart failure in primary prevention
    Sylvie Perreault
    Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada
    Br J Clin Pharmacol 66:706-16. 2008
    ..Our aim was to evaluate the impact of adherence to statins on the incidence of CHF...
  43. ncbi request reprint Cardiac transplantation for hypertrophic cardiomyopathy: a valid therapeutic option
    Marianne Coutu
    Montreal Heart Institute, Research Center and Cardiovascular Division, Montreal, Quebec, Canada
    J Heart Lung Transplant 23:413-7. 2004
    ..In this report, we analyze the clinical results of cardiac transplantation in these patients...
  44. ncbi request reprint Reduced pulmonary clearance of endothelin in congestive heart failure: a marker of secondary pulmonary hypertension
    Cezar Staniloae
    Department of Medicine, Montreal Heart Institute, Quebec, Canada
    J Card Fail 10:427-32. 2004
    ..Endothelin-1 (ET-1) levels are elevated in congestive heart failure (CHF) in relation with the severity of pulmonary hypertension. We evaluated whether a reduced pulmonary ET-1 clearance could contribute to this elevation...
  45. pmc Ten renin-angiotensin system-related gene polymorphisms in maximally treated Canadian Caucasian patients with heart failure
    Marcin Zakrzewski-Jakubiak
    Universite de Montreal, Montreal, Canada
    Br J Clin Pharmacol 65:742-51. 2008
    ..It is also acknowledged that the genotype frequency of certain gene polymorphisms varies across different ethnic groups and that a difference in gene polymorphism frequencies between healthy and heart failure patients seems to exist...
  46. pmc Digoxin and reduction of heart failure hospitalization in chronic systolic and diastolic heart failure
    Philippe Meyer
    Montreal Heart Institute, Montreal, Quebec, Canada
    Am J Cardiol 102:1681-6. 2008
    ..64, 95% CI 0.45 to 0.90, p = 0.010). In conclusion, as in patients with systolic HF, digoxin was equally effective in those with diastolic HF, who constitute half of all patients with HF, yet have few evidence-based therapeutic options...
  47. ncbi request reprint Effects of cold exposure on submaximal exercise performance and adrenergic activation in patients with congestive heart failure and the effects of beta-adrenergic blockade (carvedilol or metoprolol)
    Martine Blanchet
    Research Center, Montreal Heart Institute, Quebec, Canada
    Am J Cardiol 92:548-53. 2003
    ..Beta-blocker therapy with either metoprolol or carvedilol significantly increases submaximal exercise time and attenuates the impact of cold exposure on functional capacity...
  48. ncbi request reprint Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials
    Emmanuelle Vermes
    Department of Medicine, Montreal Heart Institute, Montreal, Canada
    Circulation 107:2926-31. 2003
    ....
  49. ncbi request reprint Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD)
    Emmanuelle Vermes
    Department of Medicine, Montreal Heart Institute, Montreal, Canada
    Circulation 107:1291-6. 2003
    ....
  50. pmc Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers
    J Malcom O Arnold
    University of Western Ontario, London, Canada
    Can J Cardiol 23:21-45. 2007
    ....
  51. ncbi request reprint 2001 Canadian Cardiovascular Society Consensus Conference on cardiac transplantation
    Heather Ross
    Can J Cardiol 19:620-54. 2003
  52. ncbi request reprint Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure
    Robert S McKelvie
    Hamilton Health Sciences, General Division, Ontario, Hamilton, Canada
    Eur Heart J 24:1727-34. 2003
    ..Patients were later randomized to metoprolol CR (M) or placebo. Examine impact of C or E (C/E), C+E, C+M/E+M, C+E+M on ventricular remodelling in heart failure (HF) over 43 weeks...
  53. ncbi request reprint Impact of nonfatal myocardial infarction on outcomes in patients with advanced heart failure and the effect of bucindolol therapy
    CHRISTOPHER M O'CONNOR
    Duke University Medical Center, Durham, North Carolina, USA
    Am J Cardiol 95:558-64. 2005
    ..Beta-blocker therapy with bucindolol appears to attenuate the risk of nonfatal MI in this population...
  54. pmc Impact of care at a multidisciplinary congestive heart failure clinic: a randomized trial
    Anique Ducharme
    Department of Medicine, Montreal Heart Institute, University of Montreal, Que
    CMAJ 173:40-5. 2005
    ..We sought to determine the impact of care at a multidisciplinary specialized outpatient congestive heart failure clinic compared with standard care...
  55. ncbi request reprint Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both
    Raymond T Yan
    The University Health Network, University of Toronto, Toronto, Ontario, Canada
    Am J Cardiol 96:698-704. 2005
    ..Serial measurements of these neurohormones may serve as useful surrogate markers of ventricular remodeling and prognosticators for clinical risk stratification...
  56. pmc Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management
    J Malcolm O Arnold
    University of Western Ontario, London, Canada
    Can J Cardiol 22:23-45. 2006
    ..The goal is to translate best evidence-based therapies into clinical practice with a measureable impact on the health of heart failure patients in Canada...
  57. pmc Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study
    Ali Ahmed
    University of Alabama at Birmingham, and VA Medical Center, Birmingham, Alabama 35294 2041, USA
    J Card Fail 14:211-8. 2008
    ..However, the effect of incident HF hospitalization (compared with no HF hospitalization) on subsequent mortality has not been studied in a propensity-matched population of chronic HF patients...
  58. ncbi request reprint Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST)
    Robert P Frantz
    Division of Cardiovascular Diseases, Mayo Clinic College of Medicine and Mayo Foundation, Rochester, Minnesota 55905, USA
    J Card Fail 13:437-44. 2007
    ..We measured serial plasma big-endothelin (Big-ET), ET-1, N-terminal atrial natriuretic peptide, and brain natriuretic peptide (BNP) in 206 patients randomized to bucindolol or placebo in Beta-Blocker Evaluation of Survival Trial (BEST)...
  59. pmc Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies
    J Malcom
    University of Western Ontario, London, Canada
    Can J Cardiol 24:21-40. 2008
    ....